|
|
|
|
|
26èmes Journées franco-belges de Pharmacochimie | | Orateurs confirmés |
| | L01 - Novel 5-HT7 antagonists for the treatment of migraine |
Dr Ali ATES
(UCB, Braine-l'Alleud, Belgium) |
|
| | L06 - Métabolomique et Chimie Médicinale, vers la découverte de nouvelles cibles thérapeutiques potentielles : application à la Dégénérescence Maculaire Liée à l’Age (DMLA) |
Dr Pascal DE TULLIO
(ULG, Liege, Belgium) |
|
| | L04 - Development of cyclin dependent kinase inhibitors. Investigation of their molecular mechanism of action |
Prof. Hervé GALONS
(SCT & PARIS DESCARTES UNIVERSITY, Paris, France) |
|
| | L02 - Foldamers: Expanding the Chemical Space |
Dr Ivan HUC
(IECB & CNRS - UNIVERSITÉ DE BORDEAUX, Bordeaux, France) |
|
| | L03 - Promoting Immune Rejection of Tumors by Blocking Tryptophan Catabolism by IDO and TDO |
Prof. Benoît VAN DEN EYNDE
(LUDWIG INSTITUTE FOR CANCER RESEARCH LTD, UCL, DE DUVE INSTITUTE, Bruxelles, Belgium) |
|
| | L05 - 3D pharmacophores in computational drug design: tools for hit discovery and lead optimization |
Prof. Gerhard WOLBER
(FREIE UNIVERSITÄT BERLIN, Berlin, Germany) |
|
| <Previous page |
|
|
|
